Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.
Aged
Cardiovascular Agents
/ therapeutic use
Cardiovascular Diseases
/ diagnosis
Cross-Sectional Studies
Diet
/ adverse effects
Europe
/ epidemiology
Female
Health Care Surveys
Health Status
Healthy Lifestyle
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/ therapeutic use
Life Style
Male
Middle Aged
Patient Compliance
Protective Factors
Registries
Risk Assessment
Risk Factors
Risk Reduction Behavior
Secondary Prevention
Sedentary Behavior
Smoking
/ adverse effects
Treatment Outcome
EUROASPIRE
cardiovascular risk factors
guidelines
lifestyle
secondary prevention
Journal
European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
pubmed:
12
2
2019
medline:
1
9
2020
entrez:
12
2
2019
Statut:
ppublish
Résumé
The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. A total of 8261 patients (females 26%) were interviewed. Nineteen per cent smoked and 55% of them were persistent smokers, 38% were obese (body mass index ≥30 kg/m A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.
Identifiants
pubmed: 30739508
doi: 10.1177/2047487318825350
doi:
Substances chimiques
Cardiovascular Agents
0
Hydroxymethylglutaryl-CoA Reductase Inhibitors
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
824-835Commentaires et corrections
Type : CommentIn
Type : CommentIn